AADI Aadi Bioscience: Nilai Bisnis

Serving as confirmation of the market valuation, this price chart demonstrates the dynamics of Aadi Bioscience (AADI), which utilizes AI and robotics to accelerate molecule discovery. The company is currently focusing on completing the pivotal PRECISION1 study on mTOR inhibitors, where the business value stands at . The enterprise's financial foundation relies exclusively on the test results of new drugs for rare tumors in the absence of current sales.

Enterprise value aggregates market capitalization and net debt, determining the actual cost of acquiring a business while accounting for all liabilities and liquid assets. The trend in the total market valuation of Aadi Bioscience reflects the capitalization of its intellectual capital, where the value of the mTOR AI platform and Fyarro patents directly impacts the investment attractiveness of the entire biopharmaceutical ecosystem.